Navigation Links
New study may show how to forestall a fatal, virus-caused immune-system meltdown

When a virus infects a person, it triggers a series of biochemical reactions in immune-system cells that literally may have life or death consequences.

Usually, the result is an effective immune response, leading to the elimination of the virus and the infected person’s recovery. But in the case of some of the world’s deadliest pathogens ?including the Ebola, Marburg and Lassa fever viruses, as well as the influenza virus strain responsible for the 1918 flu pandemic ?the immune system itself actually becomes the most dangerous element of the disease. All too often, a sudden immune overreaction sends the infected person into a shock-like state from which he or she may never recover.

Now, researchers at the University of Texas Medical Branch at Galveston (UTMB) believe they’ve found a way to spot the biochemical profile of an inappropriate immune response to viral infection ?an important step toward developing new therapies that may head off or stop an otherwise fatal immune system meltdown.

In a paper published in the February 14 issue of the Journal of Virology, highlighted in the journal’s “Spotlight?section and available now online, the scientists describe using a newly developed protein-scanning chip and a uniquely capable computer database to examine the activation and deactivation of more than a thousand proteins in cells from guinea pigs infected with two different strains of Pichinde virus. Guinea pigs infected with one of the Pichinde strains experience no ill effects, while those infected with the other strain develop symptoms similar to those seen in humans infected by the much more dangerous Lassa virus, which can cause an acute hemorrhagic fever and kills about 5,000 people a year in West Africa. (During some Lassa fever epidemics, as many as 50 percent of those diagnosed with the disease have died from it.)

“With these two forms of the virus and this new technology, we were able to compare pathogenic immune respon
'"/>

Source:University of Texas Medical Branch at Galveston


Page: 1 2 3

Related biology news :

1. Bioartificial kidney under study at MCG
2. W.M. Keck Foundation funds study of friendly microbes
3. Yellowstone microbes fueled by hydrogen, according to U. of Colorado study
4. Genome-wide mouse study yields link to human leukemia
5. Clam embryo study shows pollutant mixture adversely affects nerve cell development
6. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
7. Same mutation aided evolution in many fish species, Stanford study finds
8. Sequencing of marine bacterium will help study of cell communication
9. Genetically modified rice in China benefits farmers health, study finds
10. A new study examines how shared pathogens affect host populations
11. NYU study reveals how brains immune system fights viral encephalitis

Post Your Comments:
(Date:12/1/2009)..., Particularly in Alzheimer,s disease, nerve cell... new therapeutic options may possibly be derived f...nism. These findings have been published in the cu...cience . Until only a few years ago, neurogenesis ...ered to be impossible in the adult brain. The text...
(Date:12/1/2009)..., In July the scientists, one from the United Sta...ar on Brutus, the leader of his wolf pack, on remo... Pole. Their goal to finally find out what these ...inter in one of the harshest areas of the world.,...2003," said David Mech, a renowned U.S. Geological...
(Date:12/1/2009)..., To Charles Darwin it was an ,abominable mystery...evolutionists to this day: when did flowering plan...life on earth? Today a study in Ecology Letters ...y flowering plants gaining a major competitive adv...uent boom and abundance. , The study, by Dr Tim ...
Breaking Biology News(10 mins):New source discovered for the generation of nerve cells in the brain 2North Pole wolf emails locations to researchers 2North Pole wolf emails locations to researchers 3How did flowering plants evolve to dominate Earth? 2Gen Probe Begins U S Clinical Study of APTIMA 28R 29 Trichomonas Vaginalis Assay on the TIGRIS 28R 29 System 54674 1Gen Probe Begins U S Clinical Study of APTIMA 28R 29 Trichomonas Vaginalis Assay on the TIGRIS 28R 29 System 54674 2Gen Probe Begins U S Clinical Study of APTIMA 28R 29 Trichomonas Vaginalis Assay on the TIGRIS 28R 29 System 54674 3Gen Probe Begins U S Clinical Study of APTIMA 28R 29 Trichomonas Vaginalis Assay on the TIGRIS 28R 29 System 54674 4Worries May Worsen Peripheral Arterial Disease 54672 1Worries May Worsen Peripheral Arterial Disease 54672 2Smoking Worsens Multiple Sclerosis 54670 1Smoking Worsens Multiple Sclerosis 54670 2Smoking Worsens Multiple Sclerosis 54670 3
..., The University of Chicago has received a $1.8 ...nch a new research program on the sudden and drama...small-scale structural rearrangements result in ra...reakup of splashing water droplets, the sudden mot...at occur in a dividing cell. , The University has...
..., , TEMPE, Ariz. An unusual new species of whirli...orbisonorum in honor of the late rock n roll legen...ate University entomologist Quentin Wheeler announ...ecies Jan. 25 during a Roy Orbison Tribute Concert...Us Center for Film, Media and Popular Culture and ...
..., The Chemical Heritage Foundation (CHF) announce...Pittcon Heritage Award. Jointly sponsored by the P...pplied Spectroscopy (Pittcon) and CHF, this award ...eurial careers have shaped the instrumentation com...rstanding of the modern instrumentation sciences, ...
Other Biology News:University of Chicago launches research program in catastrophic deformation 2University of Chicago launches research program in catastrophic deformation 3Whirligig beetle gets rock 'n' roll legendary name 2Leroy Hood to receive 2008 Pittcon Heritage Award 2Leroy Hood to receive 2008 Pittcon Heritage Award 3
(Date:12/1/2009)...sia/ -- Shanghai ChemPartner, as the,flagship subs...act Research,Organization (CRO), today announced i... 50 China, ranking 3rd on the list of the fastest-... a testament to ChemPartner,s outstanding,three-ye...e results of the 2009 Deloitte Technology Fast 50 ...
(Date:12/1/2009)...nounced a collaborative research agreement with Ro...ng EpiVax’s proprietary Tregitope technology...e responses to certain drugs. In the course of the...technology will be evaluated for its effect on the... (Vocus) December 2, 2009 -- To...
(Date:12/1/2009)...British Columbia, Dec. 1 ...f The Dow Chemical Company (NYSE: DOW ), and Agr...g of a research and commercial license option agre...h access to Agrisoma,s proprietary Engineered Trai...ajor food crops, and on a non-exclusive basis, in ...
(Date:12/1/2009)...g provider of products for biological sample colle...Services will offer Oragene•DNA sample collec...nd genotyping service. , ...k , a leading provider of products for biological ...armaceutical Services will offer Oragene•DN...
Breaking Biology Technology:Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies 2Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies 3EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 2EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 3Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops 2Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops 3Tepnel Pharmaceutical Services to Offer DNA Genotek's Sample Collection Kit in its Nucleic Acid Extraction and Genotyping Service 2Tepnel Pharmaceutical Services to Offer DNA Genotek's Sample Collection Kit in its Nucleic Acid Extraction and Genotyping Service 3
...ure,BioSciences, Inc. (Nasdaq: PBIO ) today annou...o discuss its second quarter 2008 financial result...ted may listen to the,teleconference either by tel...nce and web- cast information is provided below:, ... Eastern Time (ET), To attend this teleconference...
...stments,Inc. (Amex: MGT ), a technology holding c...ology ("HCIT") sector, today reported financial re...and provided an update on,strategic milestones., ..."Our results through,the first half of 2008 reflec...onCAD technology, as we work towards gaining regul...
...o, Inc.,(Nasdaq: BNVI ), a pharmaceutical company...and effective drugs in the areas of women,s health...SVP and CFO of Bionovo, will,be presenting at the ...ce,in Boston. The presentation is scheduled to beg...the InterContinental Boston Hotel., The presentat...
Other Biology Technology:Pressure BioSciences, Inc. to Discuss Second Quarter 2008 Financial Results and Provide Business Update 2MGT Capital Investments Reports Second Quarter 2008 Financial Results and Provides Update on Recent Developments 2MGT Capital Investments Reports Second Quarter 2008 Financial Results and Provides Update on Recent Developments 3MGT Capital Investments Reports Second Quarter 2008 Financial Results and Provides Update on Recent Developments 4MGT Capital Investments Reports Second Quarter 2008 Financial Results and Provides Update on Recent Developments 5Bionovo to Present at Canaccord Adams Global Growth Conference 2
...ocedure and streamlines the bisulfite method for D...hree step reaction that takes place between cytosi...d into uracil. The EZ DNA Methylation Kits innovat...everal precipitation steps and provides researcher...
Carbohydrate Analysis Standard, 6 vials from Bio-Rad
...s a dual capability system with the ability to pro...he specimen under test. While the XCAT series prov...mages, the micro focus source also allows the syst...images. The 50 mm x 50 mm digital detector provide...
General Side Effect Profile I (GEN SEP I) from Novascreen-a Caliper Life Sciences Company
Biology Products: